Status:

WITHDRAWN

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Lead Sponsor:

Wake Forest University Health Sciences

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

This phase II trial studies ciprofloxacin compared to an inactive treatment (placebo) in diagnosing prostate cancer in patients undergoing removal of prostate cells or tissues for examination (biopsy)...

Detailed Description

PRIMARY OBJECTIVES: I. To determine the non-inferiority of the rate of detection of prostate cancer in men with decreased serum PSA values treated with placebo compared to ciprofloxacin prior to pros...

Eligibility Criteria

Inclusion

  • Abnormal serum PSA (total \> 2.5 ng/ml or other clinically important biomarker parameters, including PSA velocity and density) associated with or without normal digital rectal examination
  • Men who have elected to proceed with a diagnostic prostate biopsy
  • Any prostate size
  • Willingness and ability to give informed consent

Exclusion

  • History of prostate cancer
  • Urine culture positive for significant urinary tract infection (UTI)
  • A history of antibiotic use within one month prior to initial PSA level measurement
  • Allergy to fluoroquinolones
  • Currently taking imperative medications with significant drug-drug interaction with ciprofloxacin
  • Compromised renal function with estimated glomerular filtration rate (GFR) of \< 30 ml/min/1.73m\^2

Key Trial Info

Start Date :

July 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02252978

Start Date

July 1 2016

End Date

July 1 2016

Last Update

July 5 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Veterans Administration Medical Center.

Salisbury, North Carolina, United States, 28144

2

Comprehensive Cancer Center of Wake Forest University

Winston-Salem, North Carolina, United States, 27157